Hair transplantation versus scalp micropigmentation: A retrospective study of treatment selection in persons with female pattern hair loss.
Abstract
[BACKGROUND] Hair transplant (HT) is the standard treatment for female pattern hair loss (FPHL), but scalp micropigmentation (SMP) is an alternative. Currently, there are no criteria to help choose between HT and SMP.
[METHODS] Forty female patients with FPHL who had successfully undergone HT and SMP, were reviewed to identify factors that might help decide between treatments. Hair density (HD) and hair caliber were measured at the part line and mid-occipital region by a Folliscope. The sensitivity and specificity of HT and SMP were determined by area under the curve (AUC) and receiver operating characteristic curve.
[RESULTS] Patients were divided into HT (n = 23) and SMP (n = 17) groups. The follicular unit density (FUD) (HT: 62.06 ± 4.8551/cm; SMP: 66.59 ± 3.4971/cm) and HD (HT: 96.16 ± 16.6954/cm; SMP: 116.08 ± 17.0520/cm) were significantly different (p < 0.01) between groups. The AUC for FUD was 77.6% with a cutoff value of 66.83 and 87.0% (1-0.412) sensitivity. The AUC for HD was 82.4% with a cutoff value of 96.17 and 69.6% (1-0.118) sensitivity.
[CONCLUSIONS] HD was the most important factor when deciding between HT surgery and SMP. SMP is recommended when the HD is ≥104.6 hairs/cm and HT surgery is strongly recommended when the HD is ≤96.17 hairs/cm.
[METHODS] Forty female patients with FPHL who had successfully undergone HT and SMP, were reviewed to identify factors that might help decide between treatments. Hair density (HD) and hair caliber were measured at the part line and mid-occipital region by a Folliscope. The sensitivity and specificity of HT and SMP were determined by area under the curve (AUC) and receiver operating characteristic curve.
[RESULTS] Patients were divided into HT (n = 23) and SMP (n = 17) groups. The follicular unit density (FUD) (HT: 62.06 ± 4.8551/cm; SMP: 66.59 ± 3.4971/cm) and HD (HT: 96.16 ± 16.6954/cm; SMP: 116.08 ± 17.0520/cm) were significantly different (p < 0.01) between groups. The AUC for FUD was 77.6% with a cutoff value of 66.83 and 87.0% (1-0.412) sensitivity. The AUC for HD was 82.4% with a cutoff value of 96.17 and 69.6% (1-0.118) sensitivity.
[CONCLUSIONS] HD was the most important factor when deciding between HT surgery and SMP. SMP is recommended when the HD is ≥104.6 hairs/cm and HT surgery is strongly recommended when the HD is ≤96.17 hairs/cm.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | hair transplantation
|
모발이식 | dict | 1 | |
| 시술 | hair transplant
|
모발이식 | dict | 1 | |
| 해부 | hair
|
scispacy | 1 | ||
| 해부 | FPHL
→ female pattern hair loss
|
scispacy | 1 | ||
| 해부 | mid-occipital
|
scispacy | 1 | ||
| 해부 | follicular
|
scispacy | 1 | ||
| 해부 | AUC
→ area under the curve
|
scispacy | 1 | ||
| 합병증 | scalp
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Hair
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] HD
|
scispacy | 1 | ||
| 약물 | ≤96.17
|
scispacy | 1 | ||
| 질환 | hair loss
|
C0002170
Alopecia
|
scispacy | 1 | |
| 질환 | FPHL
→ female pattern hair loss
|
scispacy | 1 | ||
| 기타 | Hair
|
scispacy | 1 | ||
| 기타 | persons
|
scispacy | 1 | ||
| 기타 | female
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | hair caliber
|
scispacy | 1 | ||
| 기타 | FUD
→ follicular unit density
|
scispacy | 1 |
MeSH Terms
Humans; Female; Alopecia; Retrospective Studies; Adult; Scalp; Hair Follicle; Hair; Middle Aged; Young Adult; ROC Curve; Patient Selection
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- A prospective study of hair transplantation combined with concentrated growth factors for the treatment of androgenetic alopecia.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Ergonomics in Hair Transplantation: Can Technology Prevent Surgeons From Shortening Their Careers?
- Response to Tringali "Toward Standardized Density Planning in Temporal Triangular Alopecia Treated With ICV-Guided FUE".
- Toward Standardized Density Planning in Temporal Triangular Alopecia Treated With ICV-Guided FUE.